Is sleep disruption a risk factor for Alzheimer's disease?
Open accessThe DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Sleep disturbances are routinely encountered in Alzheimer’s disease (AD) and affect about 25–40% of patients in the mild-to-moderate stages of the disease. In many, sleep pathology may represent a symptom of the underlying neurodegeneration. However, a history of sleep disruption occurring years prior to onset of cognitive symptoms could represent a potential risk factor for AD. The aim of the present narrative review was to evaluate current evidence linking sleep disturbances with AD development and to understand the mechanisms that may contribute to this. Although the mechanisms by which poor sleep may contribute to AD genesis is not fully understood, emerging evidence linking disturbances in the sleep wake cycle with Aβ deposition is shedding light on the relationship between sleep pathology and the subsequent development of AD. Aβ burden appears to be enhanced by sleep-wake cycle disruptions and is suspected as being an important mechanism by which sleep disruptions contribute in AD development. Other mechanisms triggered by sleep disruption may also be involved in AD development, such as brain hypoxia, oxidative stress, circadian activity rhythms disturbances, overexpression of orexins, and blood-brain barrier impairment. Further understanding of the link between sleep disturbances and future development of AD is still needed before sleep disturbances are clearly marked as a preventable risk factor for AD. In these circumstances, early lifestyle interventions to help increase the quantity and quality of sleep may have a favorable outcome on decreasing the incidence of AD and this needs to be investigated further.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“sleep disturbance has been linked with β-amyloid (Aβ) deposition,131, 132 reduced glymphatic clearance pathways activation,133 low grade inflammation, increased Tau, hypoxia132, 134 and cardiovascular disease.135”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [132]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · cited 1×
“The accumulation of results from an imbalance between its production and clearance, which is a key early step in the pathogenesis of AD and begins 10-20 years before the appearance of cognitive symptoms – this period is known as the preclinical stage of AD [7].”
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411 · cited 2×
“occurs due to an alteration in the adrenergic signaling during sleep [49-52].”
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 1×
“In 2010, the number of people affected by dementia worldwide was estimated to be 35.6 million, and this figure is expected to double every 20 years [3].”
InfluentialHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · cited 1×
“The main pathological hallmarks of AD are the diffuse deposition of extracellular amyloid-(cid:2) (A (cid:2) ) plaques across the brain parenchyma, the aggregation of hyperphosphorylated tau protein into intracellular neurofibrillary tangles (NFT) and neuronal loss [4–6].”
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · cited 1×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 2×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 1×
“Orexins play a role in wakefulness maintenance and prevent undesirable transitions into sleep [61], as presented by orexin knock-out mice and narcoleptic patients [62-66].”
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370 · cited 1×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 1×
“Orexins play a role in wakefulness maintenance and prevent undesirable transitions into sleep [61], as presented by orexin knock-out mice and narcoleptic patients [62–66].”
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642 · cited 1×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · cited 2×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140 · cited 1×
“Due to its intense neuronal activity, it is more prone to suffer with amyloid deposition [43], which has been confirmed by imaging techniques [35, 44].”
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052 · cited 2×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960 · cited 1×
“LCns activity reaches high levels during wakefulness and falls greatly in NREM sleep, while during REM sleep it becomes quiescent [68].”
Brookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787 · cited 1×
“Risk factors for AD include advanced age [8–10], inherited genetic mutations in three genes (A (cid:2) PP, PSEN1, and PSEN2) [11–13], allele apolipoprotein E (APOE) ε 4 [14–16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19], and hypercholesterolemia [20],…”
Hypocretin (orexin) deficiency in human narcolepsy
Nishino, S., Ripley, B., Overeem, S., Lammers, G. J., & Mignot, E. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05582-8 · Cited by 1,776 · cited 1×
“Orexins play a role in wakefulness maintenance and prevent undesirable transitions into sleep [61], as presented by orexin knock-out mice and narcoleptic patients [62-66].”
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738 · cited 1×
“Findings revealing that a change of 25-40% in Aβ production can either protect or accelerate the development of AD [37, 38], suggesting that sleep disruption may potentially play an important role in contributing to AD pathogenesis.”
The sleep switch: hypothalamic control of sleep and wakefulness
Saper, C. B., Chou, T. C., & Scammell, T. E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02002-6 · Cited by 1,656 · cited 1×
“Orexins play a role in wakefulness maintenance and prevent undesirable transitions into sleep [61], as presented by orexin knock-out mice and narcoleptic patients [62–66].”
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“A (cid:2) release is a process regulated by neuronal activity [35, 39, 40].”
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Kang, J.-E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., Fujiki, N., Nishino, S., & Holtzman, D. M. (2009) · Science · doi:10.1126/science.1180962 · Cited by 1,565 · cited 8×
“The above findings are supported by research showing that sleep deprivation causes an enhancement in Aβ deposition in the APPSWE and APPSWE/PS1DE9 mouse models that are characterized by the development of significant amyloid plaques [33].”
InfluentialSchmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Genetic Ablation of Orexin Neurons in Mice Results in Narcolepsy, Hypophagia, and Obesity
Hara, J., Beuckmann, C. T., Nambu, T., Willie, J. T., Chemelli, R. M., Sinton, C. M., Sugiyama, F., Yagami, K.-I., Goto, K., Yanagisawa, M., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00293-8 · Cited by 1,403 · cited 1×
“Orexins play a role in wakefulness maintenance and prevent undesirable transitions into sleep [61], as presented by orexin knock-out mice and narcoleptic patients [62-66].”
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
Sakurai, T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2092 · Cited by 1,276 · cited 1×
“Orexins are neuropeptide hormones with several central [59] and peripheral roles [60] that have been shown to be involved in Aβ dynamics regulation [33].”
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265 · cited 2×
“The enhancement of neuronal firing causes the increase in A (cid:2) release and, consequently, concentration in the ISF [40, 41].”
Someya, S., Yu, W., Hallows, W. C., Xu, J., Vann, J. M., Leeuwenburgh, C., Tanokura, M., Denu, J. M., & Prolla, T. A. (2010) · Cell · doi:10.1016/j.cell.2010.10.002 · Cited by 1,150 · cited 1×
“The nicotinamide adenine dinucleotide-dependent deacetylase sirtuin type 3 (SirT3) upregulates antioxidant mechanisms to protect neurons against oxidative stress [70, 71], but Zhang et al.’s findings point to the fact that those mechanisms are effective in short-term wakefulness.”
The age-dependent relation of blood pressure to cognitive function and dementia
Qiu, C., Winblad, B., & Fratiglioni, L. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70141-1 · Cited by 1,138 · cited 1×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
Yaffe, K., Laffan, A. M., Harrison, S. L., Redline, S., Spira, A. P., Ensrud, K. E., Ancoli-Israel, S., & Stone, K. L. (2011) · JAMA · doi:10.1001/jama.2011.1115 · Cited by 1,137 · cited 1×
“Additionally, community-dwelling women affected by OSA were shown to present a higher risk of developing MCI or dementia [82].”
Sleep and Alzheimer disease pathology--a bidirectional relationship
Ju, Y.-E. S., Lucey, B. P., & Holtzman, D. M. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.269 · Cited by 996 · cited 1×
“Thus, A (cid:2) release increases along with the tendency for A (cid:2) plaque formation [47].”
Regional Slow Waves and Spindles in Human Sleep
Nir, Y., Staba, R. J., Andrillon, T., Vyazovskiy, V. V., Cirelli, C., Fried, I., & Tononi, G. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.043 · Cited by 924 · cited 1×
“During the wake and REM sleep phases, the firing frequency of the neurons is high, while during the slow wave sleep (SWS), cortical neurons overall activity is decreased [42].”
Neuronal activity regulates the regional vulnerability to amyloid-β deposition
Bero, A. W., Yan, P., Roh, J. H., Cirrito, J. R., Stewart, F. R., Raichle, M. E., Lee, J.-M., & Holtzman, D. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2801 · Cited by 880 · cited 3×
“A (cid:2) release is a process regulated by neuronal activity [35, 39, 40].”
Lim, A. S. P., Kowgier, M., Yu, L., Buchman, A. S., & Bennett, D. A. (2013) · Sleep · doi:10.5665/sleep.2802 · Cited by 793 · cited 2×
“In support of this hypothesis, studies show that both self-reported sleep problems [25–27] and rest fragmentation at night [28] increase the risk of developing dementia, including dementia caused by AD.”
Sleep Quality and Preclinical Alzheimer Disease
Ju, Y.-E. S., McLeland, J. S., Toedebusch, C. D., Xiong, C., Fagan, A. M., Duntley, S. P., Morris, J. C., & Holtzman, D. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2334 · Cited by 744 · cited 1×
“…cross-sectional study of 142 cognitively normal middle-aged and older adults showed that lower CSF A (cid:2) 42 levels, which indicate greater A (cid:2) deposition, were associated with poorer actigraphic measured sleep efficiency and higher frequency of waking episodes after sleep onset [31].”
Decoupling of the brain's default mode network during deep sleep
Horovitz, S. G., Braun, A. R., Carr, W. S., Picchioni, D., Balkin, T. J., Fukunaga, M., & Duyn, J. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901435106 · Cited by 685 · cited 1×
“Normally, sleep diminishes the activity of the components of DMN, as well as the connectivity between them and with other structures [45, 46].”
Aerobic exercise improves self-reported sleep and quality of life in older adults with insomnia
Reid, K. J., Baron, K. G., Lu, B., Naylor, E., Wolfe, L., & Zee, P. C. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.04.014 · Cited by 665 · cited 1×
“Potential interventions includephysicalactivityandlightexposure[96–102], strengthencircadianactivityrhythms,andimprove sleepsynchronizationinolderadults[102–106].”
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605 · cited 1×
“:3) caused by hypoxia [86–88].”
Self-reported sleep and β-amyloid deposition in community-dwelling older adults
Spira, A. P., Gamaldo, A. A., An, Y., Wu, M. N., Simonsick, E. M., Bilgel, M., Zhou, Y., Wong, D. F., Ferrucci, L., & Resnick, S. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4258 · Cited by 570
β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation
Mander, B. A., Marks, S. M., Vogel, J. W., Rao, V., Lu, B., Saletin, J. M., Ancoli-Israel, S., Jagust, W. J., & Walker, M. P. (2015) · Nature Neuroscience · doi:10.1038/nn.4035 · Cited by 569
Roh, J. H., Huang, Y., Bero, A. W., Kasten, T., Stewart, F. R., Bateman, R. J., & Holtzman, D. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004291 · Cited by 563 · cited 4×
“However, another study showed that the diurnal oscillation in the ISF A (cid:2) levels stopped occurring in a given brain region after amyloid plaques become present [36].”
InfluentialTranah, G. J., Blackwell, T., Stone, K. L., Ancoli‐Israel, S., Paudel, M. L., Ensrud, K. E., Cauley, J. A., Redline, S., Hillier, T. A., Cummings, S. R., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22468 · Cited by 525
Circadian rest—activity rhythm disturbances in alzheimer's disease
van Someren, E. J. W., Hagebeuk, E. E. O., Lijzenga, C., Scheltens, P., de Rooij, S. E. J. A., Jonker, C., Pot, A.-M., Mirmiran, M., & Swaab, D. F. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00370-3 · Cited by 452 · cited 1×
“AD patients are commonly affected by some circadian disturbances, including reduced amplitudes and phase delay of circadian variation in core body temperature and activity [94].”
Yu, W., Dittenhafer-Reed, K. E., & Denu, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355206 · Cited by 446 · cited 1×
“The nicotinamide adenine dinucleotide-dependent deacetylase sirtuin type 3 (SirT3) upregulates antioxidant mechanisms to protect neurons against oxidative stress [70, 71], but Zhang et al.’s findings point to the fact that those mechanisms are effective in short-term wakefulness.”
Ooms, S., Overeem, S., Besse, K., Rikkert, M. O., Verbeek, M., & Claassen, J. A. H. R. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1173 · Cited by 438
Anstey, K. J., Lipnicki, D. M., & Low, L.-F. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000310778.20870.ae · Cited by 437
Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F.-F., Xu, H., & Zhang, Y.-W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608856200 · Cited by 436
Tau, tangles, and Alzheimer's disease
Binder, L. I., Guillozet-Bongaarts, A. L., Garcia-Sierra, F., & Berry, R. W. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.014 · Cited by 434 · cited 1×
“The main pathological hallmarks of AD are the diffuse deposition of extracellular amyloid-(cid:2) (A (cid:2) ) plaques across the brain parenchyma, the aggregation of hyperphosphorylated tau protein into intracellular neurofibrillary tangles (NFT) and neuronal loss [4–6].”
Sleep-disordered breathing advances cognitive decline in the elderly
Osorio, R. S., Gumb, T., Pirraglia, E., Varga, A. W., Lu, S.-E., Lim, J., Wohlleber, M. E., Ducca, E. L., Koushyk, V., Glodzik, L., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001566 · Cited by 427
Regulation of Monoamine Oxidase A by Circadian-Clock Components Implies Clock Influence on Mood
Hampp, G., Ripperger, J. A., Houben, T., Schmutz, I., Blex, C., Perreau-Lenz, S., Brunk, I., Spanagel, R., Ahnert-Hilger, G., Meijer, J. H., et al. (2008) · Current Biology · doi:10.1016/j.cub.2008.04.012 · Cited by 419
Development of the Brain's Default Mode Network from Wakefulness to Slow Wave Sleep
Sämann, P. G., Wehrle, R., Hoehn, D., Spoormaker, V. I., Peters, H., Tully, C., Holsboer, F., & Czisch, M. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhq295 · Cited by 399 · cited 2×
“Normally, sleep diminishes the activity of the components of DMN, as well as the connectivity between them and with other structures [45, 46].”
Behavioral State Instability in Orexin Knock-Out Mice
Mochizuki, T., Crocker, A., McCormack, S., Yanagisawa, M., Sakurai, T., & Scammell, T. E. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0586-04.2004 · Cited by 397
Ancoli‐Israel, S., Palmer, B. W., Cooke, J. R., Corey‐Bloom, J., Fiorentino, L., Natarajan, L., Liu, L., Ayalon, L., He, F., & Loredo, J. S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01934.x · Cited by 378 · cited 1×
“Many studies point OSA as a possible reversible cause of dementia [78–80].”
Changes in the Sleep and Waking EEGs of Nondemented and Demented Elderly Subjects
PRINZ, P. N., PESKIND, E. R., VITALIANO, P. P., RASKIND, M. A., EISDORFER, C., ZEMCUZNIKOV, H. N., & GERBER, C. J. (1982) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1982.tb01279.x · Cited by 366 · cited 1×
“AD patients also present with changes in their sleep architecture that include reduced duration of rapid eye movement (REM) sleep stage bouts [23, 24], enhanced duration of stage N1 of non-REM sleep, and decreased K complexes and sleep spindles [2].”
Sleep and quantitative EEG in neurodegenerative disorders
Petit, D., Gagnon, J.-F., Fantini, M. L., Ferini-Strambi, L., & Montplaisir, J. (2004) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.02.001 · Cited by 348 · cited 1×
“AD patients also present with changes in their sleep architecture that include reduced duration of rapid eye movement (REM) sleep stage bouts [23, 24], enhanced duration of stage N1 of non-REM sleep, and decreased K complexes and sleep spindles [2].”
Ancoli-Israel, S., Gehrman, P., Martin, J. L., Shochat, T., Marler, M., Corey-Bloom, J., & Levi, L. (2003) · Behavioral Sleep Medicine · doi:10.1207/s15402010bsm0101_4 · Cited by 347 · cited 1×
“include physical activity and light exposure [96-102], strengthen circadian activity rhythms, and improve sleep synchronization in older adults [102-106].”
Sleep disturbance in mild to moderate Alzheimer’s disease
MORAN, M., LYNCH, C., WALSH, C., COEN, R., COAKLEY, D., & LAWLOR, B. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2004.12.005 · Cited by 346 · cited 1×
“Sleep disturbances are routinely encountered in patients with AD and affect 25–40% of the patients presenting with mild-to-moderate stages [21].”
Mieda, M., Willie, J. T., Hara, J., Sinton, C. M., Sakurai, T., & Yanagisawa, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400590101 · Cited by 341 · cited 1×
“fragmentation and REM sleep suppression during day time [67].”
Smoking, dementia and cognitive decline in the elderly, a systematic review
Peters, R., Poulter, R., Warner, J., Beckett, N., Burch, L., & Bulpitt, C. (2008) · BMC Geriatrics · doi:10.1186/1471-2318-8-36 · Cited by 333 · cited 1×
“…for AD include advanced age [8–10], inherited genetic mutations in three genes (A (cid:2) PP, PSEN1, and PSEN2) [11–13], allele apolipoprotein E (APOE) ε 4 [14–16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19], and hypercholesterolemia [20], among others.”
Léna, I., Parrot, S., Deschaux, O., Muffat‐Joly, S., Sauvinet, V., Renaud, B., Suaud‐Chagny, M. ‐., & Gottesmann, C. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20602 · Cited by 322 · cited 1×
“Enhanced neuronal activity across wakefulness requires an increase in their ATP production and consequently more O 2 − generation [69].”
Dowling, G. A., Burr, R. L., Van Someren, E. J. W., Hubbard, E. M., Luxenberg, J. S., Mastick, J., & Cooper, B. A. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01543.x · Cited by 313 · cited 1×
“Several sleep disorders commonly affect AD patients and these include insomnia, diminished duration of night-time sleep, increased nocturnal awakenings, and enhanced daytime sleep [22].”
Ren, Z., Iliff, J. J., Yang, L., Yang, J., Chen, X., Chen, M. J., Giese, R. N., Wang, B., Shi, X., & Nedergaard, M. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.30 · Cited by 311 · cited 1×
“The A (cid:2) clearance is also known to be two-fold faster during sleep [49], mainly because an acceleration in the ISF-to-CSF bulk flow and in the blood-brain barrier (BBB) transport [49, 53].”
(1997) · Sleep · doi:10.1093/sleep/20.1.18 · Cited by 301 · cited 1×
“include physical activity and light exposure [96-102], strengthen circadian activity rhythms, and improve sleep synchronization in older adults [102-106].”
Effect of Light Treatment on Sleep and Circadian Rhythms in Demented Nursing Home Patients
Ancoli‐Israel, S., Martin, J. L., Kripke, D. F., Marler, M., & Klauber, M. R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50060.x · Cited by 297 · cited 1×
“include physical activity and light exposure [96-102], strengthen circadian activity rhythms, and improve sleep synchronization in older adults [102-106].”
Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain
Brody, D. L., Magnoni, S., Schwetye, K. E., Spinner, M. L., Esparza, T. J., Stocchetti, N., Zipfel, G. J., & Holtzman, D. M. (2008) · Science · doi:10.1126/science.1161591 · Cited by 295
Effects of Age and Amyloid Deposition on Aβ Dynamics in the Human Central Nervous System
Huang, Y. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.235 · Cited by 277 · cited 3×
“In fact, the levels of Aβ can variate up to 30% from the highest to the lowest concentration across the day [34].”
Sleep Quality and 1-Year Incident Cognitive Impairment in Community-Dwelling Older Adults
Potvin, O., Lorrain, D., Forget, H., Dubé, M., Grenier, S., Préville, M., & Hudon, C. (2012) · Sleep · doi:10.5665/sleep.1732 · Cited by 267 · cited 1×
“In support of this hypothesis, studies show that both self-reported sleep problems [25-27] and rest fragmentation at night [28] increase the risk of developing dementia, including dementia caused by AD.”
Circadian modulation of learning and memory in fear-conditioned mice
Chaudhury, D., & Colwell, C. S. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00471-5 · Cited by 263 · cited 1×
“Potential interventions includephysicalactivityandlightexposure[96–102], strengthencircadianactivityrhythms,andimprove sleepsynchronizationinolderadults[102–106].”
Lim, A. S. P., Yu, L., Kowgier, M., Schneider, J. A., Buchman, A. S., & Bennett, D. A. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4215 · Cited by 261 · cited 1×
“People presenting with higher levels of sleep fragmentation showed a stronger association of APOE ε4 genotype with cognitive decline, post-mortem density of neurofibrillary tangles and incident AD [32].”
The Association Between Obstructive Sleep Apnea and Alzheimer’s Disease: A Meta-Analysis Perspective
Emamian, F., Khazaie, H., Tahmasian, M., Leschziner, G. D., Morrell, M. J., Hsiung, G.-Y. R., Rosenzweig, I., & Sepehry, A. A. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00078 · Cited by 258 · cited 1×
“showed, in a meta-analysis, that patients with AD present a risk five-fold higher of having obstructive sleep apnea (OSA) than cognitively normal individuals of similar age [75].”
Cooke, J. R., Ayalon, L., Palmer, B. W., Loredo, J. S., Corey-Bloom, J., Natarajan, L., Liu, L., & Ancoli-Israel, S. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27538 · Cited by 244 · cited 1×
“Many studies point OSA as a possible reversible cause of dementia [78-80].”
Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults
Sprecher, K. E., Bendlin, B. B., Racine, A. M., Okonkwo, O. C., Christian, B. T., Koscik, R. L., Sager, M. A., Asthana, S., Johnson, S. C., & Benca, R. M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.004 · Cited by 242 · cited 1×
“[48] demonstrated the complex relationship between Aβ burden and sleep disturbance.”
Hippocampal-dependent learning requires a functional circadian system
Ruby, N. F., Hwang, C. E., Wessells, C., Fernandez, F., Zhang, P., Sapolsky, R., & Heller, H. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808259105 · Cited by 234 · cited 1×
“include physical activity and light exposure [96-102], strengthen circadian activity rhythms, and improve sleep synchronization in older adults [102-106].”
Lifespan brain activity, β-amyloid, and Alzheimer's disease
Jagust, W. J., & Mormino, E. C. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.09.004 · Cited by 221 · cited 1×
“Due to its intense neuronal activity, it is more prone to suffer with amyloid deposition [43], which has been confirmed by imaging techniques [35, 44].”
Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP
Li, L., Zhang, X., Yang, D., Luo, G., Chen, S., & Le, W. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.011 · Cited by 221
Mendelsohn, A. R., & Larrick, J. W. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1530 · Cited by 209 · cited 1×
“occurs due to an alteration in the adrenergic signaling during sleep [49-52].”
Sleep Restriction Impairs Blood–Brain Barrier Function
He, J., Hsuchou, H., He, Y., Kastin, A. J., Wang, Y., & Pan, W. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2111-14.2014 · Cited by 208 · cited 1×
“He et al. [58] conducted a study with a mice chronic sleep restriction model and showed that chronic sleep restriction decreased endothelin-1 and the expression of tight junction proteins.”
Kuusisto, J., Koivisto, K., Kervinen, K., Mykkanen, L., Helkala, E.-L., Vanhanen, M., Hanninen, T., Pyorala, K., Kesaniemi, Y. A., Riekkinen, P., et al. (1994) · BMJ · doi:10.1136/bmj.309.6955.636 · Cited by 204 · cited 1×
“Risk factors for AD include advanced age [8-10], inherited genetic mutations in three genes (AβPP, PSEN1 and PSEN2) [11-13], allele apolipoprotein E (APOE) ε4 [14-16], lack of aerobic cardiovascular exercise [17], high blood pressure [18], tobacco use [19] and hypercholesterolemia [20], among others.”
A Change in Sleep Pattern May Predict Alzheimer Disease
Hahn, E. A., Wang, H.-X., Andel, R., & Fratiglioni, L. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.04.015 · Cited by 198 · cited 3×
“Hahn et al. [25], for example, conducted a study with 214 Swedish participants without dementia, aged ≥ 75 years at baseline and showed that the ones presenting with diminished self-reported sleep depth or duration were approximately 70–100% more likely to be affected by all-cause dementia and AD,…”
Light deprivation damages monoamine neurons and produces a depressive behavioral phenotype in rats
Gonzalez, M. M. C., & Aston-Jones, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703615105 · Cited by 193 · cited 1×
“include physical activity and light exposure [96-102], strengthen circadian activity rhythms, and improve sleep synchronization in older adults [102-106].”
Sleep Disturbance is Associated with Incident Dementia and Mortality
Sterniczuk, R., Theou, O., Rusak, B., & Rockwood, K. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990134 · Cited by 185 · cited 3×
“In support of this hypothesis, studies show that both self-reported sleep problems [25-27] and rest fragmentation at night [28] increase the risk of developing dementia, including dementia caused by AD.”
Functions of orexins in peripheral tissues
Heinonen, M. V., Purhonen, A. K., Mäkelä, K. A., & Herzig, K. H. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01836.x · Cited by 181 · cited 1×
“Orexins are neuropeptide hormones with several central [59] and peripheral roles [60] that have been shown to be involved in A (cid:2) dynamics regulation [33].”
Sleep spindles in Parkinson's disease may predict the development of dementia
Latreille, V., Carrier, J., Lafortune, M., Postuma, R. B., Bertrand, J.-A., Panisset, M., Chouinard, S., & Gagnon, J.-F. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.009 · Cited by 176 · cited 2×
“Sleep disturbances are usually found as non-motor manifestations of PD [107].”
Jones, S. F. (2012) · Yearbook of Pulmonary Disease · doi:10.1016/j.ypdi.2012.01.058 · Cited by 159
Lin, T.-W., Shih, Y.-H., Chen, S.-J., Lien, C.-H., Chang, C.-Y., Huang, T.-Y., Chen, S.-H., Jen, C. J., & Kuo, Y.-M. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.12.005 · Cited by 153 · cited 1×
“The BBB transport can be increased both directly (via upregulation of LRP1, transporter that allows A (cid:2) to pass through the BBB) or indirectly through the increase in glymphatic bulk flow [54–56].”
Circadian phase-shifting effects of nocturnal exercise in older compared with young adults
Baehr, E. K., Eastman, C. I., Revelle, W., Olson, S. H. L., Wolfe, L. F., & Zee, P. C. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00761.2002 · Cited by 145 · cited 1×
“include physical activity and light exposure [96-102], strengthen circadian activity rhythms, and improve sleep synchronization in older adults [102-106].”
Amyloid-β diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis
Lucey, B. P., & Bateman, R. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.035 · Cited by 144 · cited 2×
“Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive impairment [1] and considered the main cause of dementia, accounting for up to 70% of cases [2].”
Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer's disease
Troussière, A.-C., Monaca Charley, C., Salleron, J., Richard, F., Delbeuck, X., Derambure, P., Pasquier, F., & Bombois, S. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307544 · Cited by 143 · cited 1×
“Many studies point OSA as a possible reversible cause of dementia [78–80].”
Sleep disturbance and daytime sleepiness predict vascular dementia
Elwood, P. C., Bayer, A. J., Fish, M., Pickering, J., Mitchell, C., & Gallacher, J. E. J. (2011) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2009.100503 · Cited by 131 · cited 1×
“Furthermore, recent studies indicate that sleep disruptions, mainly excessive daytime sleepiness, seem to show a strong correlation with higher predictive power for subsequent VaD [115].”
Osorio, R. S., Ayappa, I., Mantua, J., Gumb, T., Varga, A., Mooney, A. M., Burschtin, O. E., Taxin, Z., During, E., Spector, N., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.030 · Cited by 124
Wheel-running in a transgenic mouse model of Alzheimer's disease: Protection or symptom?
Richter, H., Ambrée, O., Lewejohann, L., Herring, A., Keyvani, K., Paulus, W., Palme, R., Touma, C., Schäbitz, W., & Sachser, N. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.005 · Cited by 122 · cited 1×
“8 to pass through the BBB) or indirectly through the increase in glymphatic bulk flow [54-56].”
Chen, G.-J., Xu, J., Lahousse, S. A., Caggiano, N. L., & de la Monte, S. M. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2003-5305 · Cited by 115 · cited 1×
“Tau-protein hyperphosphorylation was also shown to be induced by hypoxia in mice by activating kinases which phosphorylate tau (such as glycogen synthase kinase 3 beta, mitogen-activated protein kinase and cyclin-dependent kinase 5) and inactivating the protein phosphatase 2A (PPA2), an enzyme that dephosphorylate tau…”
Treatment of Sleep Disorders in Dementia
Ooms, S., & Ju, Y.-E. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0424-3 · Cited by 113 · cited 1×
“…with disrupted sleep cycles, regardless of the cause, are necessary to both improve the quality of life of the individual and to avoid the consequences of a dysregulated sleep, which may include an acceleration of the progression of AD (see Ooms and Ju for a review on treatment in dementia [119]).”
Disrupted sleep and circadian patterns in frontotemporal dementia
Anderson, K. N., Hatfield, C., Kipps, C., Hastings, M., & Hodges, J. R. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02414.x · Cited by 109
Light Treatment for Sleep Disorders: Consensus Report: V. Age-Related Disturbances
Campbell, S. S., Terman, M., Lewy, A. J., Dijk, D.-J., Eastman, C. I., & Boulos, Z. (1995) · Journal of Biological Rhythms · doi:10.1177/074873049501000207 · Cited by 108
Dementia in the oldest old: a multi-factorial and growing public health issue
Gardner, R. C., Valcour, V., & Yaffe, K. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt181 · Cited by 108 · cited 1×
“Additionally, the onset of motor symptoms of Parkinsonism in PD and dementia with Lewy bodies appears to be preceded by REM sleep behavior disorder in many years [109–112].”
Fisk, L., Nalivaeva, N. N., Boyle, J. P., Peers, C., & Turner, A. J. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9349-2 · Cited by 107 · cited 1×
“Additionally, zinc metalloproteinase neprilysin (NEP), an enzyme that cleaves Aβ, is downregulated by hypoxia [89].”
Serum amyloid-beta levels are increased in patients with obstructive sleep apnea syndrome
Bu, X.-L., Liu, Y.-H., Wang, Q.-H., Jiao, S.-S., Zeng, F., Yao, X.-Q., Gao, D., Chen, J.-C., & Wang, Y.-J. (2015) · Scientific Reports · doi:10.1038/srep13917 · Cited by 106 · cited 1×
“[84] compared serum Aβ and P-tau 181 levels in OSA patients and individuals with simple snoring.”
Sleep characteristics and cognitive impairment in the general population: The HypnoLaus study
Haba-Rubio, J., Marti-Soler, H., Tobback, N., Andries, D., Marques-Vidal, P., Waeber, G., Vollenweider, P., von Gunten, A., Preisig, M., Castelao, E., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003557 · Cited by 96 · cited 1×
“Theseresultswereassociatedwiththe severityofthesleepdisorderedbreathing-induced intermittent hypoxia [76].”
Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice
Marien, M. R., Briley, M., & Colpaert, F. C. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90489-5 · Cited by 92
Sleep Disturbance in Dementia with Lewy Bodies and Alzheimer’s Disease: A Multicenter Analysis
Bliwise, D. L., Mercaldo, N. D., Avidan, A. Y., Boeve, B. F., Greer, S. A., & Kukull, W. A. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000326238 · Cited by 83 · cited 1×
“Eventually, sleep disturbances with night-time sleep disruptions are frequently encountered in dementia with Lewy bodies [113].”
Gao, L., Tian, S., Gao, H.-H., & Xu, Y.-Y. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9966-y · Cited by 81 · cited 1×
“12 hypoxia can also accelerate tau pathology via calpain-mediated tau hyperphosphorylation [92, 93].”
Sleep‐wake cycles in multi‐infarct dementia and dementia of the Alzheimer type
MD, J. A.-P., Masiah, A., Pillar, T., Epstein, R., Tzischinsky, O., & Lavie, P. (1991) · Neurology · doi:10.1212/wnl.41.10.1616 · Cited by 78 · cited 1×
“Patients affected by vascular dementia, in turn, suffer with sleep-wake cycle disruption and diminished sleep efficiency [114].”
Environmental Enrichment Counteracts Alzheimer’s Neurovascular Dysfunction in TgCRND8 Mice
Herring, A., Yasin, H., Ambrée, O., Sachser, N., Paulus, W., & Keyvani, K. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00094.x · Cited by 73
Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice
Rey, N. L., Jardanhazi‐Kurutz, D., Terwel, D., Kummer, M. P., Jourdan, F., Didier, A., & Heneka, M. T. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.009 · Cited by 73 · cited 1×
“Moreover, LCns damage could also accelerate neurodegeneration, as shown in previous studies with animal models of AD and Parkinson’s disease (PD) [72–74].”
O’Donnell, J., Ding, F., & Nedergaard, M. (2015) · Current Sleep Medicine Reports · doi:10.1007/s40675-014-0004-6 · Cited by 72 · cited 1×
“The probable mechanism underlying this volume increase is a change in the cell volume of astrocytes, which occurs due to an alteration in the adrenergic signaling during sleep [49–52].”
Hypoxia-Induced Tau Phosphorylation and Memory Deficit in Rats
Zhang, C.-E., Yang, X., Li, L., Sui, X., Tian, Q., Wei, W., Wang, J., & Liu, G. (2014) · Neurodegenerative Diseases · doi:10.1159/000362239 · Cited by 72 · cited 1×
“…was also shown to be induced by hypoxia in mice by activating kinases which phosphorylate tau (such as glycogen synthase kinase 3 beta, mitogen-activated protein kinase, and cyclin-dependent kinase 5) and inactivating the protein phosphatase 2A, an enzyme that dephosphorylate tau [90, 91].”
Sleep and Neurodegenerative Diseases
Chokroverty, S. (2009) · Seminars in Neurology · doi:10.1055/s-0029-1237124 · Cited by 71
Andreou, G., Vlachos, F., & Makanikas, K. (2014) · Sleep Disorders · doi:10.1155/2014/768210 · Cited by 59 · cited 1×
“OSA is characterized by nocturnal intermittent hypoxemia derived from partial or complete upper airway obstruction episodes occurring across sleep [77].”
Webster, N. J., Green, K. N., Peers, C., & Vaughan, P. F. T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01236.x · Cited by 56 · cited 1×
“-secretase which is essential to the processing of A (cid:2) PP through the non-amyloidogenic pathway [85].”
Sleep and Neurodegenerative Diseases
Bhatt, M. H., Podder, N., & Chokroverty, S. (2005) · Seminars in Neurology · doi:10.1055/s-2005-867072 · Cited by 55 · cited 2×
“Moreover, sleep disturbances characterized by enhanced nocturnal activity, excessive daytime sleepiness and reduced morning activity have all been reported in patients with frontotemporal dementia [109, 116–118].”
Strong resetting of the mammalian clock by constant light followed by constant darkness
Chen, R., Seo, D.-O., Bell, E., von Gall, C., & Lee, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2191-08.2008 · Cited by 53 · cited 1×
“include physical activity and light exposure [96-102], strengthen circadian activity rhythms, and improve sleep synchronization in older adults [102-106].”
Nishi, K., Kondo, T., & Narabayashi, H. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90941-l · Cited by 51
Sleep in Persons With Frontotemporal Dementia and Their Family Caregivers
Merrilees, J., Hubbard, E., Mastick, J., Miller, B. L., & Dowling, G. A. (2014) · Nursing Research · doi:10.1097/nnr.0000000000000024 · Cited by 51 · cited 1×
“Moreover, sleep disturbances characterized by enhanced nocturnal activity, excessive daytime sleepiness and reduced morning activity have all been reported in patients with Frontotemporal Dementia [109, 116-118].”
Lewy body disease and dementia with Lewy bodies
Kosaka, K. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.301 · Cited by 50 · cited 1×
“Additionally, the onset of motor symptoms of Parkinsonism in PD and Dementia with Lewy Bodies (DLB) appears to be preceded by REM sleep Behavior Disorder (RBD) in many years [109-112].”
Kosaka, K. (2000) · Neuropathology · doi:10.1046/j.1440-1789.2000.00301.x · Cited by 47
De Jonghe, C., Cras, P., Vanderstichele, H., Cruts, M., Vanderhoeven, I., Smouts, I., Vanmechelen, E., Martin, J.-J., Hendriks, L., & Van Broeckhoven, C. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0247 · Cited by 45
Wang, C., Xie, J., Wang, T., Xu, Y., Cai, J., Wang, X., Zhao, B., An, L., & Wang, Z. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12151 · Cited by 37 · cited 1×
“Furthermore, chronic hypoxiacanalsoacceleratetaupathologyviacalpain-mediatedtauhyperphosphorylation[92,93].”
REM Sleep Behavior Disorder (RBD) as a marker od neurodegenerative disorders
Ferini-Strambi, L. (2015) · Archives Italiennes de Biologie · doi:10.12871/000298292014238 · Cited by 24 · cited 1×
“Studies suggest that sleep disturbances presented by patients with PD, such as NREM sleep irregularities on EEG and sleep spindle alterations correlate with increased risk for developing dementia [107, 108].”
Environmental Control Interventions for Frontotemporal Dementia With Reversed Sleep—Wake Cycles
Yamakawa, M., Shigenobu, K., Makimoto, K., Canqun, Z. H. U., Ashida, N., & Tabushi, K. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317508320087 · Cited by 20 · cited 1×
“Moreover, sleep disturbances characterized by enhanced nocturnal activity, excessive daytime sleepiness and reduced morning activity have all been reported in patients with frontotemporal dementia [109, 116–118].”
Sleep and Neurologic Problems in the Elderly
Avidan, A. Y. (2006) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2006.04.010 · Cited by 19 · cited 2×
“AD patients also present with changes in their sleep architecture that include reduced duration of rapid eye movement (REM) sleep stage bouts [23, 24], enhanced duration of stage N1 of non-REM sleep, and decreased K complexes and sleep spindles [2].”
REM Sleep Behavior Disorder (RBD) as a marker of neurodegenerative disorders
Ferini‐Strambi, L., Marelli, S., Galbiati, A., Rinaldi, F., & Giora, E. (2015) · ARCHIVES ITALIENNES DE BIOLOGIE · doi:10.12871/00039822014238 · Cited by 17
Don’t Lose Sleep Over Neurodegeneration-It Helps Clear Amyloid Beta
McKinley, J., McCarthy, A. J., & Lynch, T. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00206 · Cited by 6 · cited 1×
“occurs due to an alteration in the adrenergic signaling during sleep [49-52].”
Cited by
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
“Mechanisms by which sleep might affect dementia remain unclear, but sleep disturbance has been linked with β-amyloid (Aβ) deposition, 131,132 reduced glymphatic clearance pathways activation, 133 low grade inflammation, increased Tau, hypoxia 132,134 and cardiovascular disease.”
RetractedGlymphatic System Impairment in Alzheimer’s Disease and Idiopathic Normal Pressure Hydrocephalus
Reeves, B. C., Karimy, J. K., Kundishora, A. J., Mestre, H., Cerci, H. M., Matouk, C., Alper, S. L., Lundgaard, I., Nedergaard, M., & Kahle, K. T. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.11.008 · Cited by 403
“The critical importance of glymphatic function on brain health and its functional dependence on sleep suggests that sleep dysfunction may not only accelerate the progression of dementia, but may itself be a risk factor for dementia development [84].”
BackgroundHerring, W. J., Ceesay, P., Snyder, E., Bliwise, D., Budd, K., Hutzelmann, J., Stevens, J., Lines, C., & Michelson, D. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12035 · Cited by 185
Cimenser, A., Hempel, E., Travers, T., Strozewski, N., Martin, K., Malchano, Z., & Hajós, M. (2021) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2021.746859 · Cited by 107
“In line with these observations, recent experimental and epidemiological findings demonstrate that sleep disorders represent a risk for developing AD, and a close correlation exists between sleep abnormalities and decline in activities of daily living of AD patients (Macedo et al., 2017; Hennawy et al., 2019; Bubu et…”
BackgroundResultStructural brain correlates of obstructive sleep apnoea in older adults at risk for dementia
Cross, N. E., Memarian, N., Duffy, S. L., Paquola, C., LaMonica, H. M., D'Rozario, A. L., Lewis, S. J. G., Hickie, I. B., Grunstein, R. R., & Naismith, S. L. (2018) · European Respiratory Journal · doi:10.1183/13993003.00740-2018 · Cited by 103
Metadata
- Authors
- Macedo, A. C., Balouch, S., & Tabet, N.
- Affiliations
- University of Sussex (GB)
- Brighton and Sussex Medical School (GB)
- Corresponding author
- Balouch, Sara
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2017-05-26
- Volume
- 58
- Issue
- 4
- Pages
- 993-1002
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2618941905
- Cited by
- 49
- References
- 122
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 10 · 2021: 7 · 2020: 10 · 2019: 4 · 2018: 3
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- University of Brighton Repository (University of Brighton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- sleep disruption, Alzheimer's disease
- MeSH terms
- Orexins, Alzheimer Disease, Blood-Brain Barrier, Circadian Rhythm, Humans, Risk Factors, Sleep Wake Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.